Regencell Bioscience Ltd - נכסים נקיים למניה בודדת RGC

The Regencell Bioscience (RGC) price chart on the GURU.Markets platform demonstrates the asset's volatility, which is influenced by trade wars and regulatory restrictions between China and the US. The current indicator stands at 0.03, while the company has no sales, is incurring losses, and requires constant financing. The business focuses on creating niche plant-based remedies to combat ADHD.

Efficient outsourcing of development and production allows Regencell Bioscience (RGC) to optimize operating expenses. The price action of the book value per share reflects the accumulation of the issuer's net assets. This metric is calculated as the difference between all assets and liabilities, divided by the number of shares. It determines the real value of an investor's stake, excluding market speculation. The growing trend confirms the fundamental stability of the business.